652
Participants
Start Date
November 1, 2018
Primary Completion Date
August 8, 2022
Study Completion Date
February 28, 2024
Zanubrutinib
160 mg orally twice daily
Ibrutinib
Ibrutinib 420 mg orally once daily
Middlemore Clinical Trials, Auckland
Calvary Mater Newcastle, Waratah
Gasthuiszusters Antwerpen Sint Augustinus, Wilrijk
Tauranga Hospital, Tauranga
Box Hill Hospital, Box Hill
Monash Health, Clayton
Peninsula Private Hospital, Frankston
Waikato Hospital, Hamilton
Icon Cancer Foundation, South Brisbane
Princess Alexandra Hospital, Brisbane
Royal Perth Hospital, Perth
Wellington Regional Hospital (Ccdhb), Wellington
Christchurch Hospital (Canterbury Health Laboratories), Christchurch
Columbia University Medical Center, New York
Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino, Torino
Clinical Research Alliance, Inc, Westbury
Interhem Opieka Szpitalna, Bialystok
Ico Girona, Girona
Ospedale San Raffaele, Milan
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Blue Ridge Cancer Care (Oncology and Hematology Associates of Southwest Virginia), Roanoke
Duke University Hospital, Durham
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Augusta University, Augusta
Scri Florida Cancer Specialists North, St. Petersburg
Scri Florida Cancer Specialists South, Fort Myers
Hopital Prive Sevigne, Cesson-Sévigné
Chu Tours Hopital Bretonneau Service Pneumologie, Tours
Sarah Cannon Cancer Center, Nashville
Scri Tennessee Oncology Chattanooga, Chattanooga
Hospital Universitario Marques de Valdecilla, Santander
Forrest General Hospital Cancer Center, Hattiesburg
Norton Cancer Institute Pavilion, Louisville
Hospital Virgen de La Salud, Toledo
Fakultni Nemocnice Hradec Kralove, Hradec Králové
Uniklinik Koln (Aor), Cologne
Evangelisches Krankenhaus Hamm, Hamm
Namik Kemal University, Tekirdağ
Fakultni Nemocnice Brno, Brno
Scri Hca Midwest Health, Kansas City
Nebraska Medical Center, Omaha
Chu Hopital Lyon Sud, PierreBenite
Centre Hospitalier Le Mans, Le Mans
Carti Cancer Center, Little Rock
Texas Oncology Tyler Longview, Tyler
Fakultni Nemocnice Olomouc, Olomouc
Texas Oncology San Antonio Medical Center Usor, San Antonio
Joe Arrington Cancer Research and Treatment Center, Lubbock
Rocky Mountain Cancer Centers Boulder, Boulder
Centre Hospitalier Departemental de Vendee, La Roche-sur-Yon
Centre Hospitalier Universitaire de Poitier Hopital de La Miletrie Hopital Jean Bernard, Poitiers
Comprehensive Cancer Centers of Nevada, Las Vegas
David Geffen School of Medicine At UCLA, Los Angeles
Oregon Health and Science University, Portland
Willamette Valley Cancer Center, Springfield
Va Puget Sound Health Care System, Seattle
Fred Hutchinson Cancer Research Center, Seattle
Medical Oncology Associates, Spokane
Peking University Third Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Peking Union Medical College Hospital, Beijing
Shengjing Hospital of China Medical University, Shenyang
The First Hospital of Jilin University, Changchun
Affiliated Zhongshan Hospital of Fudan University, Shanghai
Tongji Hospital of Tongji University, Shanghai
Jiangsu Province Hospital, Nanjing
Institute of Hematology and Hospital of Blood Disease, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
The First Provincial Wenzhou Hospital of Zhejiang, Wenzhou
Fujian Medical University Union Hospital, Fuzhou
Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Henan Cancer Hospital, Zhengzhou
Guangdong Provincial Peoples Hospital, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
West China Hospital, Sichuan University, Chengdu
Dana Farber Cancer Institute, Boston
Atlantic Health System, Morristown
Morristown Medical Center, Morristown
Texas Oncology Fort Worth Cancer Center, Fort Worth
The University of Texas Md Anderson Cancer Center, Houston
Fakultni Nemocnice Ostrava, Ostrava
Fondazione Policlinico Universitario Agostino Gemelli, Roma
Gelre Ziekenhuizen, Apeldoorn
Albert Schweitzer Ziekenhuis, Nijmegen
North Shore Hospital, Takapuna
Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozów
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzów
Copernicus Podmiot Leczniczy Sp Z Oo Wojewodzkie Centrum Onkologii, Gdansk
Uniwersyteckie Centrum Kliniczne, Gdansk
Malopolskie Centrum Medyczne Sc, Krakow
Wojewodzki Szpital Specjalistyczny W Legnicy, Legnica
Wielospecjalistyczne Centrum Onkologii I Traumatologii Im M Kopernika W Lodzi, Lodz
Examen Sp Z Oo, Poznan
Hospital Universitari Germans Trias I Pujol, Badalona
Hospital de La Santa Creu I Sant Pau, Barcelona
Hospital Universitario Vall Dhebron, Barcelona
Hospital Clinic I Provincial, Barcelona
Skanes Universitetssjukhus I Lund, Lund
Karolinska Universitetssjukhuset Solna, Stockholm
Nhs Grampian Ppds, Aberdeen
Birmingham Heartlands Hospital, Birmingham
The Royal Bournemouth and Christchurch Hospitals Nhs Foundation, Bournemouth
Kent and Canterbury Hospital, Canterbury
St Jamess Institute of Oncology, Leeds
Barts Health Nhs Trust, London
Norfolk and Norwich University Hospitals Nhs Foundation Trust, Norwich
Nottingham University Hospitals Nhs Trust, Nottingham
Derriford Hospital, Plymouth
Southampton General Hospital, Southampton
Sunderland Royal Hospital, Sunderland
Genesiscare Oxford, Waterlooville
Lead Sponsor
BeiGene
INDUSTRY